Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapy
暂无分享,去创建一个
S. Sonnad | S. Malkowicz | J. Tomaszewski | M. Resnick | M. Bergey | B. Brucker | D. Canter | Thomas J. Guzzo | Alan J. Wein | L. Magerfleisch
[1] E. Messing,et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. , 2009, The Journal of urology.
[2] S. Pahernik,et al. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? , 2008, BJU international.
[3] M. Terris,et al. Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH database. , 2008, The Journal of urology.
[4] M. Kattan,et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. , 2005, The Journal of urology.
[5] T. H. van der Kwast,et al. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] T. Guzzo,et al. Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. , 2007, Urology.
[7] E. Messing,et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. , 2006, JAMA.
[8] M. Kattan,et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. , 2005, Urology.
[9] M. Piérart,et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) , 2005, The Lancet.
[10] A. Jemal,et al. Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.
[11] William J Catalona,et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. , 2004, The Journal of urology.
[12] A. Partin,et al. An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series. , 2004, The Journal of urology.
[13] C. Weight,et al. Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and location. , 2004, The Journal of urology.
[14] A. Tuncel,et al. 87: Resolution of Transient Scintigraphic Lesions in Acute Pyelonephritis: What Should the Optimal time be for Distinguishing Acute Lesion and Scar? , 2004 .
[15] E. B. Butler,et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. , 2004, JAMA.
[16] E. Bergstralh,et al. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy , 2002, Cancer.
[17] A. Partin,et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. , 2001, The Urologic clinics of North America.
[18] E. Bergstralh,et al. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. , 2001, The Journal of urology.
[19] C. Öbek,et al. Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. , 1999, Urology.
[20] Taylor Murray,et al. Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.
[21] J. Epstein. Incidence and significance of positive margins in radical prostatectomy specimens. , 1996, The Urologic clinics of North America.
[22] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.